BOSTON SCIENTIFIC CORPORATION DYNAGEN CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
|
Back to Search Results |
|
Model Number G150 |
Device Problems
Off-Label Use (1494); Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Unspecified Infection (1930); Cardiac Perforation (2513); Pericardial Effusion (3271)
|
Event Date 08/19/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
The product has been received for analysis.Upon completion of the analysis of the complaint device, if there is any further relevant information from that review, a supplemental report will be filed.
|
|
Event Description
|
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) had an infection.A revision was performed and the crt-d with the right ventricular (rv) lead and right atrial (ra) lead were explanted.Additional information received indicates that there was no systemic infection and nothing was growing in the blood.This was just a pocket infection.A new device was implanted and the temporary lead removed.The old device will be returned to bsc.Furthermore, the patient has a pericardial effusion, but that this was an unrelated finding and was not caused by this procedure.No additional adverse patient effects were reported.
|
|
Manufacturer Narrative
|
The product has been received for analysis.Upon completion of the analysis of the complaint device, if there is any further relevant information from that review, a supplemental report will be filed.Correction to field b2: outcomes attributed to adverse event and f10: patient code.Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the device was performed.Detailed analysis did not confirm allegation made with the device.Moreover, the baseline testing completed on the device found no failing conditions.All testing completed on the device passed or was not applicable, therefore no problem was detected.Furthermore, 'known inherent risk' conclusion code was based on the field report of infection or infection-related conditions.Infection is a known medical risk when the skin barrier is breached.Analysis of the returned product is not able to provide relevant information for infection-related allegations.
|
|
Event Description
|
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) had an infection.A revision was performed and the crt-d with the right ventricular (rv) lead and right atrial (ra) lead were explanted.Additional information received indicates that there was no systemic infection and nothing was growing in the blood.This was just a pocket infection.A new device was implanted and the temporary lead removed.The old device will be returned to bsc.Furthermore, the patient has a pericardial effusion, but that this was an unrelated finding and was not caused by this procedure.No additional adverse patient effects were reported.
|
|
Search Alerts/Recalls
|
|
|